Long-acting, injected HIV meds can help tough-to-treat patients
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
For nearly three decades, daily antiretroviral pills have offered patients living with HIV a highly effective way to keep their infection under control.
Jul 5, 2023
0
16
Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.
Jun 29, 2023
1
15
The COVID-19 pandemic had substantial psychological impacts on the nation and around the world. New research shows patients with HIV were particularly susceptible to psychosocial challenges like depression, anxiety, substance ...
Jun 29, 2023
0
1
In 2022, there was an increase in meningococcal disease among persons with HIV, with 29 cases reported, accounting for 9.8 percent of all meningococcal disease cases, according to research published in the June 16 issue of ...
Jun 16, 2023
0
2
A common and relatively mild malady is yet another symptom people should watch for in the fight against COVID-19, experts say.
May 3, 2023
0
1
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15–18 April), finds that people living with HIV (PWH) performed worse on cognitive ...
Apr 4, 2023
0
5
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
Mar 22, 2023
0
59
Stigma negatively impacts the health of people with human immunodeficiency virus (HIV) and those with HIV who inject drugs experience stigma on multiple levels. Stigma leads to impaired utilization and retention in addiction ...
Mar 20, 2023
0
7
With successful treatment, HIV has become a chronic health condition which can be managed with life-long care.
Jan 16, 2023
0
17
A large team of researchers affiliated with a host of institutions across the U.S., working with two colleagues from Sweden, reports promising results in a phase I clinical trial aimed at testing the efficacy and safety of ...